Skip to main content
. 2011 Dec 1;10(23):4119–4127. doi: 10.4161/cc.10.23.18287

Figure 5.

Figure 5

Knockdown of C1qbp reduces migration and resistance to doxorubicin in MDA-MB-231 breast cancer cells. (A) Wound-healing assay in MDA-MB-231 cells stably transfected with either a control shRNA (Con) or one of 3 different C1qbp-specific shRNAs. (B) TUNEL staining in the different MDA-MB-231 shRNA cell lines at baseline and following exposure to 2 µM doxorubicin for 24 h. The results shown are representative of 3 and 4 independent experiments performed in duplicate. Error bars indicate SEM and *p < 0.05 vs. Con shRNA.